Antibe Therapeutics Inc. (TSE:ATE – Get Free Report) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.30 and traded as low as C$0.26. Antibe Therapeutics shares last traded at C$0.30, with a volume of 167,044 shares changing hands.
Antibe Therapeutics Price Performance
The stock has a market capitalization of C$15.64 million, a P/E ratio of -0.84 and a beta of 0.19. The company has a debt-to-equity ratio of 0.29, a quick ratio of 9.58 and a current ratio of 10.06. The company’s 50-day moving average is C$0.30.
About Antibe Therapeutics
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
Featured Articles
- Five stocks we like better than Antibe Therapeutics
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- About the Markup Calculator
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
